{"id":"https://openalex.org/W56859202","doi":null,"title":"Clinical impact of HFE Mutations in portuguese patients with Chronic Hepatitis C","display_name":"Clinical impact of HFE Mutations in portuguese patients with Chronic Hepatitis C","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W56859202","mag":"56859202"},"language":"en","primary_location":{"id":"pmh:oai:repositorio.insa.pt:10400.18/1573","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.18/1573","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference object"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10400.18/1573","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101994113","display_name":"Joana Pereira de Carvalho\u2010Ferreira","orcid":"https://orcid.org/0000-0001-9038-2185","observed_orcids":["https://orcid.org/0000-0001-9038-2185"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joana Pereira de Carvalho\u2010Ferreira","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9038-2185","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042099097","display_name":"Cil\u00e9nia Baldaia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cil\u00e9nia Baldaia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043212403","display_name":"\u00c2ngela In\u00e1cio","orcid":"https://orcid.org/0000-0003-0396-6743","observed_orcids":["https://orcid.org/0000-0003-0396-6743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c2ngela In\u00e1cio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0396-6743","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030155801","display_name":"Manuel Bicho","orcid":"https://orcid.org/0000-0002-5773-5687","observed_orcids":["https://orcid.org/0000-0002-5773-5687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuel Bicho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5773-5687","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069766900","display_name":"Jos\u00e9 Velosa","orcid":"https://orcid.org/0000-0001-6644-0234","observed_orcids":["https://orcid.org/0000-0001-6644-0234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Velosa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6644-0234","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077479770","display_name":"Paula Faustino","orcid":"https://orcid.org/0000-0002-6269-4867","observed_orcids":["https://orcid.org/0000-0002-6269-4867"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula Faustino","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6269-4867","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089663554","display_name":"F. Serejo","orcid":"https://orcid.org/0000-0002-1541-843X","observed_orcids":["https://orcid.org/0000-0002-1541-843X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Serejo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00593472,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hfe-mutations","display_name":"HFE gene mutations","score":0.9110000133514404},{"id":"https://openalex.org/keywords/iron-metabolism","display_name":"iron metabolism","score":0.7979999780654907},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.597000002861023},{"id":"https://openalex.org/keywords/antiviral-treatment-response","display_name":"antiviral treatment response","score":0.8069999814033508},{"id":"https://openalex.org/keywords/hcv-genotypes","display_name":"HCV genotypes","score":0.5809999704360962},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.746999979019165},{"id":"https://openalex.org/keywords/steatosis","display_name":"steatosis","score":0.7889999747276306},{"id":"https://openalex.org/keywords/necroinflammation","display_name":"necroinflammation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antioxidant-capacity","display_name":"antioxidant capacity","score":0.4169999957084656},{"id":"https://openalex.org/keywords/portuguese-patients","display_name":"Portuguese patients","score":0.628000020980835},{"id":"https://openalex.org/keywords/hfe-gene","display_name":"HFE gene","score":0.3059999942779541},{"id":"https://openalex.org/keywords/hereditary-hemochromatosis","display_name":"hereditary hemochromatosis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/homa","display_name":"HOMA","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C41260117","wikidata":"https://www.wikidata.org/wiki/Q668064","display_name":"Hepatology","level":2,"score":0.732958197593689},{"id":"https://openalex.org/C2776590208","wikidata":"https://www.wikidata.org/wiki/Q2025687","display_name":"Hemochromatosis","level":2,"score":0.7045414447784424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.664509654045105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6347489356994629},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.500396728515625},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.47895413637161255},{"id":"https://openalex.org/C3018783601","wikidata":"https://www.wikidata.org/wiki/Q3144934","display_name":"Hereditary hemochromatosis","level":3,"score":0.4742005467414856},{"id":"https://openalex.org/C2776768029","wikidata":"https://www.wikidata.org/wiki/Q14882371","display_name":"Hepcidin","level":3,"score":0.47069668769836426},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.4135659635066986},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33719778060913086},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.312605619430542},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.18844863772392273}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:repositorio.insa.pt:10400.18/1573","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.18/1573","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference object"},{"id":"mag:56859202","doi":null,"is_oa":false,"landing_page_url":"https://repositorio.insa.pt/bitstream/10400.18/1573/1/Poster%20BioIron%202013%20_HepC_Fe_final.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:repositorio.insa.pt:10400.18/1573","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10400.18/1573","pdf_url":null,"source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"conference object"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1976507886","https://openalex.org/W2078515174","https://openalex.org/W2101145483","https://openalex.org/W2109466536"],"related_works":["https://openalex.org/W2113550355","https://openalex.org/W1932469879","https://openalex.org/W1554762386","https://openalex.org/W2010074150","https://openalex.org/W2014371615","https://openalex.org/W1987742751","https://openalex.org/W2120177848","https://openalex.org/W2277808627","https://openalex.org/W2040395090","https://openalex.org/W4405163207"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Chronic":[1],"hepatitis":[2,381],"C":[3],"(CHC)":[4],"is":[5],"often":[6],"associated":[7],"with":[8,68,98,195,257,340,349],"alterations":[9],"in":[10,42,56,240,269,276,282,338,373],"iron":[11,159,311,359],"and":[12,21,52,63,71,82,89,102,112,117,127,140,157,164,172,183,190,216,254,275,279,312,319,343,347,354,370,376],"lipid":[13,151],"metabolisms,":[14],"which":[15],"may":[16,36],"affect":[17],"the":[18,22,31,45,64,243,258,270,288,325],"long-term":[19],"prognosis":[20],"response":[23,108,114],"to":[24,38,293,335],"antiviral":[25,100,261],"treatment.":[26],"Some":[27],"studies":[28],"suggested":[29],"that":[30,305],"occurrence":[32],"of":[33,47,59,129,199,201,242,260,272,287,368,379],"HFE":[34,49],"mutations":[35,50],"contribute":[37],"modulate":[39],"these":[40],"metabolisms":[41],"CHC.":[43],"Here,":[44],"prevalence":[46],"two":[48,94,221,227],"(C282Y":[51],"H63D)":[53],"was":[54,178,193,238,250,333],"determined":[55,120],"a":[57,267,365],"group":[58],"Portuguese":[60],"CHC":[61,78],"patients":[62,79,222,339,348],"findings":[65],"were":[66,96,119,132,143,186,246],"correlated":[67],"clinical,":[69],"histological":[70,377],"virulogical":[72],"features.":[73],"MATERIALS":[74],"AND":[75],"METHODS:":[76],"183":[77],"(118":[80],"males":[81],"65":[83],"females),":[84],"mean":[85],"age":[86],"45.84\u00b111.46":[87],"years":[88],"IMC":[90],"25.45\u00b13.96":[91],"Kg/m2.":[92],"Eighty":[93],"(44.8%)":[95],"treated":[97],"standard":[99,146],"therapy":[101],"divided":[103],"into":[104],"3":[105],"groups:":[106],"non":[107],"(NR)-25.6%,":[109],"relapse":[110],"(RR)-9.8%":[111],"sustained":[113],"(SR)-64.6%.":[115],"HCV-RNA":[116],"genotype":[118],"by":[121,134,145,180,188],"PCR.":[122],"Liver":[123],"steatosis,":[124],"fibrosis":[125,351],"stage":[126],"degree":[128,271],"necroinflammation":[130,273,342],"(grading)":[131,274],"assessed":[133],"liver":[135,208],"biopsy":[136],"(Peter":[137],"Scheuer":[138],"score)":[139],"clinical":[141,331,375],"parameters":[142],"measured":[144],"techniques:":[147],"AST,":[148],"ALT,":[149],"GGT,":[150],"profile":[152],"(LDL,":[153],"HDL,":[154],"total":[155,283,321,326],"cholesterol":[156,284,322],"triglycerides),":[158],"metabolism":[160],"(iron,":[161],"ferritin,":[162],"transferrin":[163,165,313],"saturation),":[166],"haptoglobin,":[167],"ceruloplasmin,":[168],"insulin,":[169],"glucose,":[170],"peptide-C":[171],"HOMA.":[173],"Antioxidant":[174],"potential":[175],"(tGSH/GSSG":[176],"ratio)":[177],"evaluated":[179],"spectrofluorimetry.":[181],"HFE_H63D":[182,253,369],"C282Y":[184,236,371],"polymorphisms":[185,256,372],"analyzed":[187],"PCR-RFLP":[189],"statistical":[191],"analysis":[192],"performed":[194],"SPSS":[196],"16.0":[197],"(level":[198],"significance":[200],"p<0.05).":[202],"Patients\u2019":[203],"exclusion":[204],"criteria:":[205],"other":[206],"chronic":[207,380],"diseases,":[209],"alcohol":[210],"ingestion":[211],">40g/day,":[212],"HIV":[213],"infection,":[214],"metabolic":[215],"autoimmune":[217],"diseases.":[218],"RESULTS:":[219],"Sixty":[220],"(33.9%)":[223],"carried":[224],"one":[225],"or":[226],"mutant":[228,289],"H63D":[229],"allele":[230,290],"(HD+DD),":[231],"being":[232],"4.4%":[233],"homozygous":[234],"(DD).":[235],"polymorphism":[237],"present":[239],"5.5%":[241],"patients;":[244],"all":[245],"heterozygous.":[247],"No":[248],"difference":[249],"found":[251,334],"comparing":[252,292],"_C282Y":[255],"type":[259],"response.":[262],"Regarding":[263],"H63D,":[264],"we":[265],"observe":[266],"decrease":[268],"tGSH/GSSG":[277],"ratio":[278],"an":[280],"increase":[281],"for":[285],"carriers":[286],"(HD+DD)":[291],"HH":[294],"individuals":[295],"(p=0.004;":[296],"p=0.006;":[297],"p=0.042,":[298],"respectively).":[299],"For":[300],"C282Y,":[301],"our":[302],"study":[303],"revealed":[304],"heterozygous":[306],"CY":[307],"had":[308],"higher":[309,350,357],"serum":[310,358],"saturation":[314],"levels":[315],"(p=0.038;":[316],"p=0.006,":[317],"respectively)":[318],"lower":[320],"(p<0.0001).":[323],"In":[324],"studied":[327],"population,":[328],"this":[329],"last":[330],"parameter":[332],"be":[336],"increased":[337],"less":[341],"steatosis":[344],"(p=0.023;":[345],"p=0.046)":[346],"stages":[352],"(moderate":[353],"intense)":[355],"showed":[356],"levels.":[360],"CONCLUSIONS:":[361],"These":[362],"data":[363],"suggest":[364],"relevant":[366],"role":[367],"some":[374],"features":[378],"C.":[382]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}